FinnGen: an expedition into genomics and medicine

FinnGen is a research project in genomics and personalized medicine. It is large public-private partnership that has collected and analysed genome and health data from 500,000 Finnish biobank donors to understand the genetic basis of diseases. FinnGen is a now expanding into understanding the progression and biological mechanisms of diseases. FinnGen provides a world-class resource for further breakthroughs in disease prevention, diagnosis, and treatment and a outlook into our genetic make-up.

FinnGen data freeze 10 results now publicly available!

Access the results here

Samples from biobanks

The FinnGen study will utilise samples collected by a nationwide network of Finnish biobanks. The study is based on combining genome information with digital health care data from national health registries.

Take part

Samples are needed from all over Finland in the thousands, because solutions in the field of personalized healthcare can be found only by looking at large masses. Every Finn can be a part of the FinnGen study by giving a biobank consent.

Everybody benefits

The genome data produced during the project will be owned by the Finnish biobanks, and remain available for researcher purposes. The medical breakthroughs that arise from the project will eventually benefit health care systems and patients globally.

Collaboration is the key

The collaborative nature of the FinnGen research project is exceptional compared to many other studies. The study involves all the same actors as drug development. With this open cooperation, we hope to speed up the emergence of new innovations.

Data freeze 10 results and summary statistics now available!

Results can be browsed online using the FinnGen web browser and the summary statistics downloaded

This data freeze consists of >412,000 individuals, more than 21.3 M variants and 2,408 disease endpoints. To get more information about how to access the results and summary statistics, please follow this link:

Access results

Birches with the text "New FinnGen GWAS results".

News

Inherited predisposition for higher muscle strength may protect against common morbidities

A study conducted at the Faculty of Sport and Health Sciences at the University of Jyväskylä showed that a genetic predisposition for higher muscle strength predicts a longer lifespan and a lower risk for developing common diseases. This is the most comprehensive international study to date on hereditary muscle strength and its relationship to morbidity. The genome and health data of more than 340,000 Finns was used in the research.

A woman and a man doing a kettlebell workout.

10.4.2024

New gene defect discovery helps to unlock the mystery of severe infectious mononucleosis

A new hereditary disease was found in Finns, which manifests as severe infectious mononucleosis. The genetic defect can lead to the treatment of many different diseases.

Two scientists, holding a DNA molecule in their hands.

28.3.2024

Tweets by FinnGen_FI

New accessible and engaging FinnGen communication resource available!

Scroll through the website to learn about the FinnGen project, its goals, processes and its impact in Finland and around the world.

Can you imagine what genetic diversity looks like in large populations or visualise where genes are located on chromosomes in relation to each other? We teamed up with Aalto University to produce a resource that uses data visualisation to tell the FinnGen story to a wider audience.

Enter the scrollytelling website

Screenshots from the scrollytelling website.

Communicating genetic research with the help of information design

FinnGen brings together the nation-wide network of Finnish biobanks.

Every Finn can be a part of the FinnGen study by giving a biobank consent.

Samples available

629 000

Samples needed by 2023: 520 000

Current data freeze

520 210

combined genotype and health registry data